About Dr. Prashant Mehta
Dr. Prashant Mehta is a distinguished Medical Oncologist, Haemato-Oncologist, and Bone Marrow Transplant specialist, serving as Senior Associate Director of Medical Oncology at Amrita Hospital, Faridabad. An alumnus of AIIMS New Delhi (DM Medical Oncology) and Fred Hutchinson Cancer Research Center, Seattle (USA), he is a leading medical oncologist in India with over 16 years of experience.
- 16+ years of experience in medical oncology, haemato-oncology, and BMT
- Performed the first Bone Marrow Transplant, first Total Body Irradiation-based transplant, and first MUD transplant in the Faridabad region
- More than 60 publications in national and international peer-reviewed journals and book chapters
- Principal Investigator for 20+ clinical trials
- Recipient of the Prof. G.S. Bhattacharya Memorial Award for Best All-Rounder Oncologist in India (ICON, 2021)
- Leads Amrita's CAR-T Cell Therapy programme to broaden access to cellular therapy in India
Qualifications & Credentials
Medical Degrees
- MBBS — Maulana Azad Medical College (MAMC), New Delhi, India — 2006
- MD — General Medicine — Lady Hardinge Medical College, New Delhi, India — 2010
- DM — Medical Oncology — All India Institute of Medical Sciences (AIIMS), New Delhi, India — 2014
Fellowships & Special Training
- Visiting Physician Fellowship in BMT / Cellular Therapy — Fred Hutchinson Cancer Research Center, Seattle, USA — 2016
Certifications & Accreditations
- European Society for Medical Oncology (ESMO) Certification — 2015
- Delhi Medical Council Registration
- Joint Editor and Web Editor — Indian Journal of Medical and Paediatric Oncology (IJMPO)
Areas of Expertise
Major Conditions Treated
- Acute Leukaemia (ALL & AML) — Children & Adults
- Lymphoma (Hodgkin & Non-Hodgkin)
- Chronic Lymphocytic Leukaemia (CLL)
- Lung Cancer
- Gynaecological Cancers (Ovarian, Cervical, Endometrial)
- Sarcoma & Melanoma
- Breast Cancer
- Gallbladder Cancer
- Head & Neck Cancers
- Aplastic Anaemia & Blood Disorders
Sub-specialties
- Bone Marrow Transplantation & Cellular Therapy: Clinical lead for haploidentical BMT in adults and children — one of the best BMT specialists in India for international patients seeking curative transplant in Faridabad.
- CAR-T Cell Therapy: Leads Amrita's cellular therapy programme to bring CD19-targeted CAR-T therapy to patients with relapsed/refractory blood cancers, working in collaboration with global researchers.
- Precision Oncology & Immunotherapy: Expert in targeted therapy and checkpoint inhibitors for solid tumours and lymphoid neoplasms — a sought-after medical oncologist in India for complex cancer treatment.
Advanced Procedures & Treatments
- Allogeneic & Haploidentical Bone Marrow Transplantation
- CAR-T Cell Therapy (CD19-targeted)
- Immunotherapy / Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4)
- Targeted Therapy (EGFR, ALK, BCR-ABL, BTK inhibitors)
- Intensive Chemotherapy for Acute Leukaemia
- Reduced-Intensity Conditioning Transplants
- Clofarabine-Based Conditioning for Relapsed/Refractory Leukaemia
- PARP Inhibitor Therapy for Hereditary BRCA-associated Cancers
List of Disease and Treatment for which Dr. Prashant Mehta can be consulted
Professional Experience
Current Affiliation
- Amrita Hospital, Sector 88, Faridabad, Haryana — Senior Associate Director, Medical Oncology / Haemato-Oncology / BMT — 2016–Present; Programme Head for Lymphoid Leukemias, Lymphomas, BMT, CAR-T, Thoracic Oncology & Sarcoma
Past Affiliations
- Artemis Health Institute, Gurgaon — Consultant, Medical Oncology / Haematology / BMT — 2015–2016
- All India Institute of Medical Sciences (AIIMS), New Delhi — Senior Resident, Medical Oncology & BMT — 2012–2014
Academic & Research Roles
- Joint Editor and Web Editor — Indian Journal of Medical and Paediatric Oncology (IJMPO)
- Principal Investigator — 20+ clinical trials in haemato-oncology and solid tumours
- Founder Member — Science and Cost Cancer Consortium (improving access to cancer care through evidence-based pharmacokinetics)
Key Achievements
- Performed the first BMT, first TBI-based transplant, and first MUD transplant in Faridabad region
- 60+ peer-reviewed publications and book chapters in national and international journals
- Principal Investigator for 20+ clinical trials
- Recognised as one of the best all-round oncologists in India by ICON (2021)
Awards & Recognitions
National & International Awards
- Prof. G.S. Bhattacharya Memorial Award — Best All-Rounder Oncologist in India, Indian Cooperative Oncology Network (ICON) — 2021
- Meghna Krishna Baweja Memorial Award — All-Round Excellence in 1st Professional MBBS, Maulana Azad Medical College — 2001–2002
Professional Memberships
- European Society for Medical Oncology (ESMO)
- Indian Cooperative Oncology Network (ICON)
- Indian Society of Medical & Paediatric Oncology (ISMPO)
- Science and Cost Cancer Consortium — Founder Member
Research & Publications
Published Papers (Selected)
- Mehta P, Bothra SJ. "PARP inhibitors in hereditary breast and ovarian cancer and other cancers: A review." Advances in Genetics. 2021;108:35–80. doi: 10.1016/bs.adgen.2021.08.002.
- Mehta P, Arora R. "Clofarabine-based conditioning for T-cell replete haploidentical HSCT for relapsed/refractory acute leukemia using peripheral blood stem cell grafts and post-transplantation cyclophosphamide." (Conference presentation, TCT 2020).
- Mehta P, et al. "Feasibility of Cyclosporine Instead of Tacrolimus after Haploidentical Transplantation Using PBSC Grafts with Post-Transplant Cyclophosphamide." Biology of Blood and Marrow Transplantation. 2020;26(Suppl 3):S279.
- Pramanik R, Srivastava P, Sharma A, Mehta P, et al. "Management of Head-and-Neck Cancer during COVID-19 Crisis: A Medical Oncology Perspective." Indian Journal of Medical and Paediatric Oncology. 2020.
- Batra A, Mehta P, et al. "Breast cancer treatment during the COVID-19 pandemic." Indian Journal of Medical and Paediatric Oncology. 2020.
Ongoing Research & Clinical Interests
- CAR-T cell therapy accessibility in India and low-income settings
- Haploidentical BMT outcomes in high-risk haematological malignancies
- Precision medicine and molecular profiling in solid tumours and lymphomas
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Medical Oncology Consultation | ₹1,000 – ₹2,500 | $12 – $30 |
| Bone Marrow Transplant (Haploidentical) | ₹18,00,000 – ₹32,00,000 | $21,600 – $38,400 |
| Chemotherapy (per cycle, regimen-dependent) | ₹25,000 – ₹1,50,000 | $300 – $1,800 |
| Immunotherapy / Checkpoint Inhibitors (per cycle) | ₹80,000 – ₹2,50,000 | $960 – $3,000 |
| Targeted Therapy (per month, drug-dependent) | ₹50,000 – ₹3,00,000 | $600 – $3,600 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Prashant Mehta use in Oncology treatment?
Dr. Prashant Mehta employs CAR-T cell therapy, haploidentical BMT with post-transplantation cyclophosphamide, clofarabine-based conditioning for relapsed leukaemia, PARP inhibitor therapy, PD-1/PD-L1 checkpoint immunotherapy, and molecular profiling for precision oncology.
2. What conditions does Dr. Prashant Mehta specialise in treating?
Dr. Prashant Mehta specialises in acute leukaemia, lymphoma, CLL, lung cancer, gynaecological cancers, sarcoma, melanoma, and aplastic anaemia. International patients seeking best haemato-oncology treatment in India or bone marrow transplant in Faridabad consult him regularly.
3. How do I book an appointment with Dr. Prashant Mehta?
Appointments with Dr. Prashant Mehta can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Prashant Mehta?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Prashant Mehta, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Prashant Mehta offer second opinions for Oncology cases?
Yes. Second opinion consultations are available for patients wishing to review their cancer diagnosis, molecular pathology, or treatment plan with a leading medical oncologist and BMT specialist in India.
Sarvodaya Hospital, Faridabad - India
Hina Khan’s Cancer Story – Inspiring Battle With Stage 3 Breast Cancer
